Moran Wealth Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.68M Buy
141,150
+77,245
+121% +$3.76M 0.21% 159
2026
Q1
$2.74M Sell
63,905
-4,987
-7% -$214K 0.08% 272
2025
Q4
$3.02M Sell
68,892
-2,925
-4% -$121K 0.09% 253
2025
Q3
$2.97M Sell
71,817
-23,495
-25% -$944K 0.09% 247
2025
Q2
$4.2M Buy
95,312
+2,040
+2% +$81.5K 0.13% 207
2025
Q1
$3.44M Buy
93,272
+65,186
+232% +$2.32M 0.12% 226
2024
Q4
$935K Sell
28,086
-1,860
-6% -$60.3K 0.03% 301
2024
Q3
$777K Buy
29,946
+11,119
+59% +$276K 0.02% 322
2024
Q2
$423K Buy
18,827
+6,969
+59% +$155K 0.01% 352
2024
Q1
$281K Buy
+11,858
New +$264K 0.01% 389

Other funds holding EXEL

Moran Wealth Management's EXEL Position: Q2 2026 in Review

Moran Wealth Management increased its Exelixis (EXEL) stake by 121% in Q2 2026, buying an estimated $3.76M and bringing the position to 141,150 shares worth $7.68M. The position accounts for 0.21% of the portfolio, ranked #159.

Moran Wealth Management first reported a position in EXEL in Q1 2024 and has held it in 10 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Moran Wealth Management held 141,150 shares of Exelixis worth $7.68M as of Q2 2026.
  • Moran Wealth Management bought 77,245 Exelixis shares in Q2 2026, an estimated $3.76M.
  • Exelixis made up 0.21% of Moran Wealth Management's portfolio in Q2 2026, its #159 holding.
  • Moran Wealth Management first reported a position in Exelixis in Q1 2024 and has held it in 10 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Moran Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.